Growth and fatty acid profiles of VLBW infants receiving a multicomponent lipid emulsion from birth.

Published on Apr 1, 2014in Journal of Pediatric Gastroenterology and Nutrition2.839
· DOI :10.1097/MPG.0000000000000280
Hester Vlaardingerbroek12
Estimated H-index: 12
(Boston Children's Hospital),
Marijn J. Vermeulen16
Estimated H-index: 16
+ 3 AuthorsJohannes B. van Goudoever68
Estimated H-index: 68
Sources
Abstract
Very-low-birth-weight (VLBW) infants are dependent on parenteral nutrition after birth. A parenteral lipid emulsion with a multicomponent composition may improve growth and neurodevelopment and may prevent liver injury, which is often observed in association with long-term parenteral nutrition with pure soybean oil. Our aim was to evaluate the safety and efficacy of a multicomponent lipid emulsion containing 30% soybean oil, 30% medium-chain triacylglycerol, 25% olive oil, and 15% fish oil compared with a conventional pure soybean oil emulsion in VLBW infants. We conducted a double-blind randomized controlled trial in VLBW infants randomized to parenteral nutrition with the multicomponent (study group) or pure soybean oil emulsion (control group) from birth at a dose of 2 to 3 g · kg(-1) · day(-1) until the infants were receiving full enteral nutrition. We assessed efficacy by growth rates and measuring plasma fatty acid profiles (representative subset). Safety was evaluated by assessing hematologic and biochemical parameters, potentially harmful phytosterol concentrations (same subset), and clinical neonatal outcome parameters. Ninety-six infants were included (subsets n = 21). The multicomponent emulsion was associated with higher weight and head circumference z scores during admission. Plasma eicosapentaenoic acid and docosahexaenoic acid concentrations were higher in the study group. The hematological, biochemical, and neonatal outcomes were not different between groups, whereas the plasma concentrations of phytosterols were higher in the control group. The multicomponent lipid emulsion was well tolerated and associated with improved growth and higher plasma fatty acid profiles in VLBW infants in comparison with the pure soybean oil emulsion
📖 Papers frequently viewed together
References42
Newest
#1Hester Vlaardingerbroek (Boston Children's Hospital)H-Index: 12
#2Marijn J. Vermeulen (Boston Children's Hospital)H-Index: 16
Last. Johannes B. van Goudoever (VUmc: VU University Medical Center)H-Index: 68
view all 9 authors...
Objective To assess the efficacy and safety of early parenteral lipid and high-dose amino acid (AA) administration from birth onwards in very low birth weight (VLBW, birth weight Study design VLBW infants (n = 144; birth weight 862 ± 218 g; gestational age 27.4 ± 2.2 weeks) were randomized to receive 2.4 g of AA kg −1 ·d −1 (control group), or 2.4 g AA kg −1 ·d −1 plus 2-3 g lipids kg −1 ·d −1 (AA + lipid group), or 3.6 g AA kg −1 ·d −1 plus 2-3 g lipids kg −1 ·d −1 (high AA + lipid group) from ...
Source
#1Hester Vlaardingerbroek (Boston Children's Hospital)H-Index: 12
Last. Johannes B. van GoudoeverH-Index: 68
view all 5 authors...
textabstractBackground: The use of intravenous lipid emulsions in preterm infants has been limited by concerns regarding impaired lipid tolerance. As a result, the time of initiation of parenteral lipid infusion to very-low-birth-weight (VLBW) infants varies widely among different neonatal intensive care units. However, lipids provide energy for protein synthesis and supply essential fatty acids that are necessary for central nervous system development. Objective: The objective was to summarize ...
Source
#1Oscar D Rangel-Huerta (UGR: University of Granada)H-Index: 11
#2Concepción M. Aguilera (UGR: University of Granada)H-Index: 31
Last. Angel Gil (UGR: University of Granada)H-Index: 85
view all 4 authors...
Abstract Inflammation is part of the normal host response to infection and injury. Eicosanoids, cytokines, chemokines, adhesion molecules and other inflammatory molecules are frequently produced during this process. Numerous studies in humans have documented the inflammation-limiting properties of omega-3 fatty acids, but only a few have been randomised clinical trials. The aim of this study was to perform a systematic search of randomised clinical trials on omega-3 fatty acids and inflammatory ...
Source
#1Shawn J. Rangel (Harvard University)H-Index: 30
#2Casey M. Calkins (Children's Hospital of Wisconsin)H-Index: 29
Last. Daniel H. Teitelbaum (UM: University of Michigan)H-Index: 68
view all 8 authors...
Abstract Objective The aim of this study was to review evidence-based data addressing key clinical questions regarding parenteral nutrition–associated cholestasis (PNAC) and parenteral nutrition–associated liver disease (PNALD) in children. Data Source Data were obtained from PubMed, Medicine databases of the English literature (up to October 2010), and the Cochrane Database of Systematic Reviews. Study Selection The review of PNAC/PNALD has been divided into 4 areas to simplify one's understand...
Source
#1Camilia R. Martin (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 26
#2Deborah Dasilva (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 6
Last. Steven D. Freedman (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 55
view all 14 authors...
Objective To measure the changes in whole blood fatty acid levels in premature infants and evaluate associations between these changes and neonatal morbidities. Study design This was a retrospective cohort study of 88 infants born at Results Docosahexaenoic acid (DHA) and arachidonic acid levels declined rapidly in the first postnatal week, with a concomitant increase in linoleic acid levels. Decreased DHA level was associated with an increased risk of CLD (OR, 2.5; 95% CI, 1.3-5.0). Decreased a...
Source
Objective To compare plasma lipids in preterm infants given a new lipid emulsion containing 10% fish oil, 50% medium-chain triacylglycerols, and 40% soybean oil, compared with a standard preparation containing 50:50 medium-chain triacylglycerols: soybean oil. Study design Preterm infants weighing Results On day 7, the infants receiving fish oil lipid had significantly lower plasma phospholipids, cholesterol esters, and free cholesterol but similar triglyceride concentrations. They also had signi...
Source
#1Erika Tomsits (Semmelweis University)H-Index: 7
#2Margit Pataki (Semmelweis University)H-Index: 1
Last. Lajos Szollár (Semmelweis University)H-Index: 8
view all 6 authors...
Objectives: Safety, tolerability, and efficacy of a novel lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOFlipid 20%) with reduced n-6 fatty acids (FA), increased monounsaturated and n-3 FA, and enriched in vitamin E were evaluated in premature infants compared with a soybean oil-based emulsion. Patients and Methods: Sixty (30/30) premature neonates (age 3-7 days, gestational age <34 weeks, birth weights 1000-2500 g) received parenteral...
Source
Background: SMOFlipid 20% is an intravenous lipid emulsion (ILE) containing soybean oil, medium-chain triglycerides, olive oil, and fish oil developed to provide energy, essential fatty acids (FAs), and long-chain ω-3 FAs as a mixed emulsion containing α-tocopherol. The aim was to assess the efficacy and safety of this new ILE in pediatric patients receiving home parenteral nutrition (HPN) compared with soybean oil emulsion (SOE). Methods: This single-center, randomized, double-blind study inclu...
Source
#1Hau D. Le (Boston Children's Hospital)H-Index: 24
#2Vincent E de Meijer (Boston Children's Hospital)H-Index: 24
Last. Mark Puder (Boston Children's Hospital)H-Index: 53
view all 6 authors...
Background: Parenteral nutrition (PN) is a life-saving therapy but has been associated with dyslipidemia. Because fish oil has been shown to have positive effects on lipid profiles, the authors hypothesize that a parenteral fish oil lipid emulsion will improve lipid profiles in children who are PN dependent. Methods: The authors examined the lipid profiles of a unique cohort of 10 children who were exclusively administered a fish oil–based lipid emulsion while on PN for a median duration of 14 w...
Source
Background: Fetal growth and development require n–3 (omega-3) long-chain polyunsaturated fatty acids, but mechanisms for their placental transfer are not well understood. Objective: We assessed distribution and human placental transfer of 13 C-labeled fatty acids (FAs) 12 h after oral application. Design: Eleven pregnant women received 0.5 mg [ 13 C]palmitic acid ( 13 C-PA; 16:0), 0.5 mg [ 13 C]oleic acid ( 13 C-OA; 18:1n–9), 0.5 mg [ 13 C]linoleic acid ( 13 C-LA; 18:2n–6), and 0.1 mg [ 13 C]do...
Source
Cited By55
Newest
#1Olivier Goulet (Necker-Enfants Malades Hospital)H-Index: 50
#2Antonin Lamaziere (University of Paris)H-Index: 18
Last. Cécile Lambe (Necker-Enfants Malades Hospital)H-Index: 8
view all 6 authors...
BACKGROUND Composite lipid emulsions containing soybean oil (30%), medium-chain triglycerides (30%), olive oil (25%), and fish oil (15%) (SMOF) are now widely used. OBJECTIVES We aimed to evaluate the tolerance, the efficiency, and the erythrocyte fatty acid (FA) profile for children on long-term home parenteral nutrition (HPN) receiving a composite fish oil-based emulsion (FOLE). METHODS At baseline, children (n = 46) with severe intestinal failure highly dependent on parenteral nutrition (PN) ...
Source
#1Susannah FrancoH-Index: 1
#2Pavel Goriacko (Montefiore Medical Center)H-Index: 3
Last. Toshiba Morgan-Joseph (Montefiore Medical Center)H-Index: 1
view all 4 authors...
Background Parenteral nutrition (PN) is crucial for the improvement of long-term outcomes in very low birth weight (VLBW) neonates. Lipid injectable emulsions are a key component of PN, as they contain essential fatty acids and provide energy critical for brain growth. Prolonged administration increases risk of intestinal failure-associated liver disease, including cholestasis, and other complications. Methods This is a retrospective, quasi-experimental cohort study of 215 VLBW neonates. The pri...
Source
#9Bo Hu (HUST: Huazhong University of Science and Technology)H-Index: 30
#10Yanan Li (HUST: Huazhong University of Science and Technology)H-Index: 22
Abstract null null Diabetic retinopathy (DR) is one of the common complications in diabetic patients. Nowadays, VEGF pathway is subject to extensive research. However, about 27% of the patients have a poor visual outcome, with 50% still having edema after two years’ treatment of diabetic macular edema (DME) with ranibizumab. Docosahexaenoic acid (DHA), the primary ω-3 long-chain polyunsaturated fatty acid (LC-PUFA), reduces abnormal neovascularization and alleviates neovascular eye diseases. A s...
Source
#1Katie Huff (IU: Indiana University)H-Index: 1
#2Francine D. Breckler (Riley Hospital for Children)H-Index: 11
Last. Charles Vanderpool (IU: Indiana University)H-Index: 2
view all 5 authors...
BACKGROUND Intestinal failure associated liver disease (IFALD) occurs in up to 85% of neonates on prolonged parenteral nutrition. Strategies for treatment of IFALD include alternative lipid therapies such as Smoflipid® (Fresenius Kabi). In this study we reviewed our institutional Smoflipid use including predictors of patient response and safety concerns. METHODS This is a retrospective chart review of all pediatric patients who received Smoflipid therapy over a two-year period at Riley Hospital ...
Source
#1Rachel Leigh Jackson (Intermountain Healthcare)H-Index: 1
#2Phillip Zachary White (Intermountain Healthcare)H-Index: 1
Last. Jennifer Zalla (Intermountain Healthcare)H-Index: 1
view all 3 authors...
BACKGROUND: Parenteral nutrition (PN) is critical for the growth and development of premature neonates who are unable to reach nutrition goals enterally. Using soybean-oil emulsions in PN is a risk factor for cholestasis, leading to alternative dosing strategies including a reduction in total lipid prescribed. Recently, SMOFlipid has been utilized with the goal of avoiding cholestasis while maintaining energy intake. The aim of our study was to compare the incidence of PN-associated cholestasis ...
Source
#1Dalton K Hudgins (Novant Health)
#2Amy P Holmes (Boston Children's Hospital)
Last. J Brock Harris (Wingate University)
view all 4 authors...
PURPOSE Results of a study comparing the safety and efficacy outcomes with use of a soybean oil-based injectable lipid emulsion (SO-ILE) vs a 4-oil alternative product in a neonatal population are presented. METHODS In an institutional review board-approved, multicenter retrospective review, the medical records of 328 patients who were born at a gestational age of ≤34 weeks, had a birth weight of 500 to 2,000 g, were admitted to one of 2 neonatal intensive care units (NICUs) within a large healt...
Source
#1Simonetta Costa (UCSC: Catholic University of the Sacred Heart)H-Index: 7
#2Carmen Cocca (UCSC: Catholic University of the Sacred Heart)H-Index: 2
Last. Giovanni Vento (UCSC: Catholic University of the Sacred Heart)H-Index: 27
view all 8 authors...
BACKGROUND The growth of very low-birth-weight (VLBW) infants relies, to a large extent, on parenteral nutrition (PN) during the early weeks of life. Despite the parenteral nutrients supply, extrauterine growth restriction remains the main concern for these infants. A parenteral multicomponent lipid emulsion (MLE) might improve growth and neurological outcomes, delivering fats for brain growth that the traditional soybean-based lipid emulsion (SLE) fails to provide. We hypothesize that the use o...
Source
OBJECTIVE A mixture of soybean, medium-chain triglycerides, olive, and fish oils (SMOF) contains higher α-tocopherol and n-3 polyunsaturated fatty acids and lower phytosterol content compared with conventional soybean oil lipid emulsions (SOLE). We sought to characterize plasma total fatty acid profiles (FAPs) and assess the tolerability of long-term SMOF therapy in extremely preterm infants. METHODS We retrospectively evaluated infants born null 0.2) or hypertriglyceridemia (TG >200 mg/dL) with...
Source
#1Panos Papandreou (UoA: National and Kapodistrian University of Athens)H-Index: 1
#2Aristea Gioxari (HUA: Harokopio University)H-Index: 12
Last. Tania Siahanidou (UoA: National and Kapodistrian University of Athens)H-Index: 15
view all 6 authors...
Intravenous administration of pure soybean oil emulsions high in linoleic acid may lead to inflammation and lipid peroxidation in preterm neonates. We aimed to investigate the effects of a medium-chain triglyceride (MCT)/ω-3 polyunsaturated fatty acid (PUFA)-enriched intravenous fat emulsion (IVFE) on plasma fatty acid (FA) profile and serum interleukin-6 (IL-6) in preterm neonates. In this double-blind randomized study, 92 preterm neonates (gestational age < 32 weeks, birth weight < 1500 g) wer...
Source
#2Barbara E. Cormack (University of Auckland)H-Index: 13
Last. Frank H. Bloomfield (University of Auckland)H-Index: 33
view all 4 authors...
BACKGROUND: Very low-birth-weight (VLBW; birth weight < 1500 g) infants are often dependent on intravenous nutrition after birth. Conventional soy-based intravenous lipid emulsions (Soy LE) are associated with inflammatory and metabolic complications that may be harmful to preterm infants. Evidence to support any clinical benefit associated with newer multicomponent emulsions (Mixed LE), remains inconsistent and unsubstantiated in appropriate studies. This retrospective study aimed to determine ...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.